Revised Criteria for Diagnosis and Staging of Alzheimer Disease
Dr. Greg Cooper and Dr. Clifford R. Jack Jr. discuss objective criteria for diagnosis and staging Alzheimer disease, highlighting recent advancements in biomarkers to bridge the gap between research…
Read the full articleYou might also wanna read
Advances in Alzheimer's disease research: Biomarkers, therapies, and immune mechanisms
Alzheimer’s disease is driven by pathological brain changes that progressively impair memory and cognition, with current treatment options b
Tests May Hint at Alzheimer's 18 Years Before Diagnosis
Ongoing research into Alzheimer's and dementia offers a beacon of hope. Yet, the journey toward significant breakthroughs is complex and unc
The Unintended Harms of Alzheimer's Biomarker Testing: Why Amyloid Isn't a Diagnosis
Families may struggle to cope with abuse in a digital era. Psychologists can help.
abpp.org·1mo ago
Revolutionizing Alzheimer's Research: A New Approach to Harmonize PET Scans
A breakthrough in PET scan harmonization promises improved diagnostic accuracy for Alzheimer's by integrating data from different tracers. F
Researchers Announce Potential 2024 Release of Groundbreaking Alzheimer's Blood Test
Researchers have announced the release of a groundbreaking blood test for Alzheimer's disease. This could mark a significant advancement in
New Biomarker Approach Maps Preclinical Alzheimer’s Disease Risk
Combined tau biomarkers track early cognitive decline and forecast structural neurodegeneration in preclinical Alzheimer's disease. The post
Comments
Sign in to join the conversation.
No comments yet. Be the first.